ASH 2010 Conference Coverage

Vulnerability to Infection Increases for Breast Cancer Survivors Treated With Chemotherapy

Chemotherapy for breast cancer can affect the body's ability to ward off common illnesses.

Comprehensive Genetic Profiling Possible for Central Nervous System Tumors

New genetic testing can assist brain cancer treatment planning.

It Is Never Too Late for Breast Cancer Survivors to Stop Smoking

Smokers have good reason to quit the habit both before and after a breast cancer diagnosis.

ALK-positive anaplastic large cell lymphoma with prominent bone involvement in a 13-year-old boy

[OncoTargets and Therapy] Anaplastic large cell lymphoma (ALCL) frequently involves the bone marrow, but primary or secondary involvement to the bone is rare. This article examines a case of anaplastic lymphoma kinase positive ALCL with prominent bone involvement in a young boy.

Inferior Outcomes for African Americans With Pediatric Hodgkin Lymphoma

African-American pediatric patients with Hodgkin lymphoma still display a considerable survival disparity when compared to their white and Hispanic peers.

First-line Afatinib Benefits Lung Cancer Patients With Brain Metastases

For patients with non-small cell lung cancer who have EGFR mutations and brain metastases, progression-free survival was improved with afatinib compared to chemotherapy.

Basic Research Data Pivotal for First FDA Approval of Immunotherapy for Pediatric Cancer

New research has helped influence the FDA's decision to approve the first immunotherapy for pediatric patients.

Risk of Breast Cancer or Thyroid Cancer Higher Following a Diagnosis of the Other Cancer Type

Review found increased odds for developing thyroid or breast cancer as secondary malignancy after the other cancer type was diagnosed.

HIV and Cancer: Dual Diagnosis Compounds Challenges in Coping

Each of these diagnoses has many implications for both nurses and patients. When combined, nurses need to anticipate that these patients may have greater psychosocial challenges.

Cola Consumption May Increase Erlotinib Absorption in Patients Taking PPIs

Cola consumption resulted in a clinically relevant increase in the absorption of the kinase inhibitor erlotinib in patients also taking the proton pump inhibitor (PPI) esomeprazole, according to study data.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs